China · Delayed Price · Currency is CNY Byhealth Statistics
Total Valuation
Byhealth has a market cap or net worth of CNY 16.06 billion. The enterprise value is 11.19 billion.
| Market Cap | 16.06B |
| Enterprise Value | 11.19B |
Important Dates
The last earnings date was Saturday, August 8, 2026.
| Earnings Date | Aug 8, 2026 |
| Ex-Dividend Date | Apr 21, 2026 |
Share Statistics
Byhealth has 1.68 billion shares outstanding. The number of shares has decreased by -4.21% in one year.
| Current Share Class | 1.68B |
| Shares Outstanding | 1.68B |
| Shares Change (YoY) | -4.21% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 45.79% |
| Owned by Institutions (%) | 9.08% |
| Float | 908.06M |
Valuation Ratios
The trailing PE ratio is 24.32 and the forward PE ratio is 22.59.
| PE Ratio | 24.32 |
| Forward PE | 22.59 |
| PS Ratio | 2.51 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.72 |
| P/FCF Ratio | 25.57 |
| P/OCF Ratio | 21.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.45, with an EV/FCF ratio of 17.81.
| EV / Earnings | 17.24 |
| EV / Sales | 1.75 |
| EV / EBITDA | 11.45 |
| EV / EBIT | 15.48 |
| EV / FCF | 17.81 |
Financial Position
The company has a current ratio of 3.26, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.26 |
| Quick Ratio | 2.84 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | 1.72 |
| Interest Coverage | 68.48 |
Financial Efficiency
Return on equity (ROE) is 5.98% and return on invested capital (ROIC) is 9.14%.
| Return on Equity (ROE) | 5.98% |
| Return on Assets (ROA) | 3.34% |
| Return on Invested Capital (ROIC) | 9.14% |
| Return on Capital Employed (ROCE) | 6.50% |
| Weighted Average Cost of Capital (WACC) | 5.79% |
| Revenue Per Employee | 2.23M |
| Profits Per Employee | 226,285 |
| Employee Count | 2,867 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 3.12 |
Taxes
In the past 12 months, Byhealth has paid 165.31 million in taxes.
| Income Tax | 165.31M |
| Effective Tax Rate | 19.94% |
Stock Price Statistics
The stock price has decreased by -22.72% in the last 52 weeks. The beta is 0.34, so Byhealth's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -22.72% |
| 50-Day Moving Average | 9.82 |
| 200-Day Moving Average | 11.10 |
| Relative Strength Index (RSI) | 41.32 |
| Average Volume (20 Days) | 16,863,556 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Byhealth had revenue of CNY 6.40 billion and earned 648.76 million in profits. Earnings per share was 0.39.
| Revenue | 6.40B |
| Gross Profit | 4.40B |
| Operating Income | 722.49M |
| Pretax Income | 828.95M |
| Net Income | 648.76M |
| EBITDA | 976.89M |
| EBIT | 722.49M |
| Earnings Per Share (EPS) | 0.39 |
Balance Sheet
The company has 6.02 billion in cash and 1.08 billion in debt, with a net cash position of 4.94 billion or 2.95 per share.
| Cash & Cash Equivalents | 6.02B |
| Total Debt | 1.08B |
| Net Cash | 4.94B |
| Net Cash Per Share | 2.95 |
| Equity (Book Value) | 10.94B |
| Book Value Per Share | 6.49 |
| Working Capital | 5.24B |
Cash Flow
In the last 12 months, operating cash flow was 750.05 million and capital expenditures -121.83 million, giving a free cash flow of 628.22 million.
| Operating Cash Flow | 750.05M |
| Capital Expenditures | -121.83M |
| Depreciation & Amortization | 254.40M |
| Net Borrowing | 228.51M |
| Free Cash Flow | 628.22M |
| FCF Per Share | 0.38 |
Margins
Gross margin is 68.66%, with operating and profit margins of 11.28% and 10.13%.
| Gross Margin | 68.66% |
| Operating Margin | 11.28% |
| Pretax Margin | 12.94% |
| Profit Margin | 10.13% |
| EBITDA Margin | 15.25% |
| EBIT Margin | 11.28% |
| FCF Margin | 9.81% |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 4.64%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 4.64% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 116.53% |
| Buyback Yield | 4.21% |
| Shareholder Yield | 8.84% |
| Earnings Yield | 4.04% |
| FCF Yield | 3.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Byhealth is 11.55, which is 20.44% higher than the current price. The consensus rating is "Buy".
| Price Target | 11.55 |
| Price Target Difference | 20.44% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 10.23% |
| EPS Growth Forecast (3Y) | 17.56% |
Stock Splits
The last stock split was on April 1, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Apr 1, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Byhealth has an Altman Z-Score of 6.14 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.14 |
| Piotroski F-Score | 6 |